Publications by authors named "David Perret"

Claim this Profile
A
Autoantibodies to posttranslationally modified type II collagen as potential biomarkers for rheumatoid arthritis.
Rocky Strollo, Frederique Ponchel, Vivianne Malmström, Paola Rizzo, Michele Bombardieri, David Perret

Arthritis Rheum· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a web 2.0 based software for the design and the facilitation of cognitive stimulation workshops.
Evelyne Klinger, Elise Martinet, David Perret

Stud Health Technol Inform· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversal of some viral IL-6 electrostatic properties compared to IL-6 contributes to a loss of alpha receptor component recruitment.
David Perret, François Rousseau, Vinh Tran, Hugues Gascan

Proteins· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two different contact sites are recruited by cardiotrophin-like cytokine (CLC) to generate the CLC/CLF and CLC/sCNTFRalpha composite cytokines.
David Perret, Catherine Guillet, Greg Elson, Josy Froger, Hélène Plun-Favreau

J Biol Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neuropoietin, a new IL-6-related cytokine signaling through the ciliary neurotrophic factor receptor.
Damien Derouet, François Rousseau, Fabienne Alfonsi, Josy Froger, Jacques Hermann, David Perret

Proc Natl Acad Sci U S A· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GPL, a novel cytokine receptor related to GP130 and leukemia inhibitory factor receptor.
Caroline Diveu, Eric Lelièvre, David Perret, Anne-Hélène Lagrue Lak-Hal, Josy Froger

J Biol Chem· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Hélène Plun-Favreau, David Perret, Caroline Diveu, Josy Froger, Sylvie Chevalier

J Biol Chem· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis